Aurora Spine Corporation Attends Lytham Partners Fall 2022 Investor Conference, The Canadian Business Journal

CARLSBAD, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF) develops innovative medical devices that improve is a designer and manufacturer. Spinal Surgery Outcomes today announced it will be attending the Lytham Partners Fall 2022 Investor Conference, which will take place virtually September 28-29, 2022. Virtual investor meeting.

Our webcast presentation is panel discussion Hosted by Aurora Spine President and CEO Trent Northcutt and Krissy Ramey. The discussion title is: Simplifying the Complex – A panel discussion with physicians who use Aurora Products. /asg.v/2112539 or our his website. The webcast will also be archived and made available for playback.

Executives participate in virtual 1:1 meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners 1×.[email protected] Or register at www.lythampartners.com/fall2022invreg.

About Aurora Spine

Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.

Neither TSX Venture Exchange nor its regulated service providers (as those terms are defined in the TSX Venture Exchange Policy) are responsible for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains material known and unknown risks beyond Aurora Spine’s control, including but not limited to those described in “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Information”. It contains forward-looking information that involves risks and uncertainties. Aurora Spine’s final prospectus (collectively, “Forward-Looking Information”). Forward-looking information in this news release includes information regarding the proposed use and success of the company’s products in surgical procedures. Aurora Spine advises investors in Aurora Spine securities about important factors that could cause Aurora Spine’s actual results to differ materially from those projected by the forward-looking statements contained in this news release. I warn you. Statements that express or relate to expectations, beliefs, plans, objectives, assumptions, or discussions of future events or performance are not historical facts, may be forward-looking statements, and may not represent actual results or outcomes. It may involve estimates, assumptions and uncertainties that may cause it to differ unilaterally from those expressed in such forward-looking statements. There is no guarantee that the expectations set forth herein will prove correct. These statements are current as of the date of this press release and Aurora Spine undertakes no obligation to update or revise them to reflect new events or circumstances.

contact:

Aurora Spine Corporation

Trent Northcutt
President and Chief Executive Officer
(760) 424-2004

Chad Close
CFO
(760) 424-2004
www.aurora-spine.com

Adam Lowensteiner
Lytham Partners LLC
Phoenix | Phoenix | New York
Phone: 646-829-9700
[email protected]

CBJ Newsmaker